Abdelbaset Ali Mohmed al-Megrahi, who is suffering from terminal prostate cancer, no longer receives hospital treatment after ending the course of chemotherapy that he had been given after returning to his homeland last August. Professor Karol Sikora, the London-based doctor who examined Megrahi and predicted he would be dead by last October, admitted this weekend that the fact the bomber is still alive might be “difficult” for the families of the 270 victims of the attack.